CELGENE CORP /DE/
Insider CIK 816284 · ALQA 10% owner · GBIM 10% owner · XLRN 10% owner · STRO 10% owner · AGIO 10% owner · EPZM 10% owner · JNCE 10% owner · CRSP 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XLRN ACCELERON PHARMA INC | X Exercise deriv | 2020-07-09 | 2020-07-13 | 38,979 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-07-09 | 2020-07-13 | 2,241 | $102.28 | $229.2K | 7,008,510 | SEC↗ |
| XLRN ACCELERON PHARMA INC | X Exercise | 2020-07-09 | 2020-07-13 | 38,979 | $5.88 | $229.2K | 7,010,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2020-07-01 | 2020-07-06 | 108,108 | $92.50 | $10.00M | 6,971,772 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | P Buy | 2019-11-12 | 2019-11-14 | 403,225 | $31.00 | $12.50M | 1,777,824 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2019-01-18 | 2019-01-22 | 706,206 | $43.00 | $30.37M | 6,824,685 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-11-21 | 2017-12-07 | 80,000 | $19.25 | $1.54M | 4,173,019 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-02 | 18,097,331 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-02 | 8,338,892 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-02 | 2,845,114 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-02 | 18,726,075 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-02 | 1,726,197 | — | $0 | 1,726,197 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | P Buy | 2018-01-23 | 2018-01-23 | 851,154 | $67.00 | $57.03M | 1,374,599 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | P Buy | 2018-01-23 | 2018-01-31 | 851,154 | $67.00 | $57.03M | 1,374,599 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-12-04 | 2017-12-07 | 30,485 | $19.47 | $593.5K | 3,722,534 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-12-01 | 2017-12-07 | 87,991 | $19.10 | $1.68M | 3,753,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-30 | 2017-12-07 | 12,666 | $19.04 | $241.2K | 3,841,010 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-29 | 2017-12-07 | 4,263 | $19.25 | $82.1K | 3,853,676 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-28 | 2017-12-07 | 5,080 | $19.22 | $97.6K | 3,857,939 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-27 | 2017-12-07 | 27,990 | $19.75 | $552.8K | 3,863,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-24 | 2017-12-07 | 26,010 | $20.00 | $520.2K | 3,891,009 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-22 | 2017-12-07 | 256,000 | $19.76 | $5.06M | 3,917,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-20 | 2017-12-07 | 158,718 | $19.02 | $3.02M | 4,253,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-17 | 2017-12-07 | 51,282 | $18.44 | $945.6K | 4,411,737 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-16 | 2017-12-07 | 105,000 | $18.39 | $1.93M | 4,463,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-15 | 2017-12-07 | 15,000 | $17.67 | $265.1K | 4,568,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-14 | 2017-12-07 | 14,907 | $17.19 | $256.3K | 4,583,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-13 | 2017-12-07 | 65,093 | $17.76 | $1.16M | 4,597,926 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-10 | 2017-12-07 | 10,000 | $17.28 | $172.8K | 4,663,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-09 | 2017-12-07 | 20,000 | $17.08 | $341.6K | 4,673,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-08 | 2017-12-07 | 16,875 | $18.06 | $304.8K | 4,693,019 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-07 | 2017-12-07 | 23,000 | $18.54 | $426.4K | 4,709,894 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-06 | 2017-12-07 | 79,327 | $18.89 | $1.50M | 4,732,894 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-11-03 | 2017-12-07 | 22,759 | $19.10 | $434.7K | 4,812,221 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2017-09-25 | 2017-09-25 | 745,592 | $37.00 | $27.59M | 6,118,479 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | P Buy | 2017-04-24 | 2017-04-24 | 624,575 | $49.50 | $30.92M | 1,856,353 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | J Other | 2017-04-11 | 2017-04-13 | 296,277 | — | $0 | 7,342,377 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | P Buy | 2017-02-27 | 2017-03-01 | 4,000,000 | $0.50 | $2.00M | 7,046,100 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-01 | 10,448,100 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | P Buy | 2017-02-01 | 2017-02-01 | 625,000 | $16.00 | $10.00M | 3,456,463 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-01 | 2,831,463 | — | $0 | 2,831,463 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion deriv | 2016-10-24 | 2016-10-26 | 4,034,830 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion deriv | 2016-10-24 | 2016-10-27 | 4,034,830 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2016-10-24 | 2016-10-26 | 800,150 | $14.00 | $11.20M | 4,834,980 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion | 2016-10-24 | 2016-10-26 | 4,034,830 | — | $0 | 4,034,830 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2016-10-24 | 2016-10-27 | 800,150 | $14.00 | $11.20M | 4,834,980 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion | 2016-10-24 | 2016-10-27 | 4,034,830 | — | $0 | 4,034,830 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2016-01-11 | 2016-01-11 | 800,000 | $40.00 | $32.00M | 5,372,887 | SEC↗ |
| ALQA Alliqua BioMedical, Inc. | P Buy | 2015-05-04 | 2015-05-04 | 659,340 | $4.55 | $3.00M | 3,046,100 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion deriv | 2014-07-08 | 2014-07-08 | 2,160,682 | — | $0 | 0 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion deriv | 2014-07-08 | 2014-07-08 | 8,650,519 | — | $0 | 0 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion deriv | 2014-07-08 | 2014-07-08 | 1,765,888 | — | $0 | 0 | SEC↗ |
| GBIM GLOBEIMMUNE INC | P Buy | 2014-07-08 | 2014-07-08 | 200,000 | $10.00 | $2.00M | 600,670 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion | 2014-07-08 | 2014-07-08 | 56,256 | — | $0 | 400,670 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion | 2014-07-08 | 2014-07-08 | 275,582 | — | $0 | 344,414 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion | 2014-07-08 | 2014-07-08 | 68,832 | — | $0 | 68,832 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2014-05-05 | 2014-05-06 | 1,100,000 | $42.86 | $47.15M | 4,572,887 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | P Buy | 2014-04-29 | 2014-04-30 | 294,800 | $44.00 | $12.97M | 1,003,133 | SEC↗ |
| ALQA Alliqua, Inc. | A Award deriv | 2014-04-14 | 2014-04-15 | 142,857 | — | $0 | 142,857 | SEC↗ |
| ALQA Alliqua, Inc. | P Buy | 2014-04-14 | 2014-04-15 | 714,286 | $7.00 | $5.00M | 2,386,760 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2014-02-10 | 2014-02-11 | 340,000 | $29.25 | $9.95M | 3,674,640 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2014-01-28 | 2014-01-29 | 300,000 | $50.00 | $15.00M | 3,472,887 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 1,990,446 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other deriv | 2013-09-24 | 2013-09-26 | 36,496 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion deriv | 2013-09-24 | 2013-09-26 | 457,875 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | J Other | 2013-09-24 | 2013-09-26 | 57,899 | — | $0 | 515,774 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 1,990,446 | — | $0 | 2,506,220 | SEC↗ |
| XLRN ACCELERON PHARMA INC | P Buy | 2013-09-24 | 2013-09-26 | 666,667 | $15.00 | $10.00M | 3,172,887 | SEC↗ |
| XLRN ACCELERON PHARMA INC | C Conversion | 2013-09-24 | 2013-09-26 | 457,875 | — | $0 | 457,875 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-30 | 5,190,551 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-30 | 5,839,496 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion | 2013-07-29 | 2013-07-30 | 1,887,473 | — | $0 | 1,887,473 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | P Buy | 2013-07-29 | 2013-07-30 | 708,333 | $18.00 | $12.75M | 708,333 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion | 2013-07-29 | 2013-07-30 | 2,123,453 | — | $0 | 4,010,926 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-06 | 9,803,922 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-06 | 3,267,974 | — | $0 | 3,267,974 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-06-05 | 2013-06-06 | 66,666 | $15.00 | $1000.0K | 3,334,640 | SEC↗ |